Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.

A graphics abstract of the final publication.

The findings, published today in the European Heart Journal and funded by the National Institute for Health Research (NIHR) ARC OxTV and NIHR Community Healthcare MedTech and Invitro Diagnostics Co-operative, used data from over 1,000 general practices across the UK to examine how the use of a simple blood test administered by GPs varied over time, between 1 January 2004 and 31 December 2018.

Dr Clare Taylor, GP and NIHR Academic Clinical Lecturer at the Nuffield Department of Primary Care Health Sciences, University of Oxford said:

“As a GP I often see patients with heart failure. It is a serious, life-threatening condition that that affects around one million people in the UK alone. There are 200,000 new cases each year, and around 80% of these patients are only diagnosed when they are so unwell they’ve needed to be admitted to hospital.

As GPs we can do a simple blood test in primary care which tells us if heart failure is likely. If it’s raised, we can refer for a heart scan and assessment by a cardiologist. The heart failure detection rate in our study over a 14-year period remained the same, suggesting there are still missed opportunities for us to diagnose sooner through testing.

There are many treatments that improve both quality of life and survival, but we need to give them earlier so patients benefit sooner and avoid hospitalisation, which is why this testing is so important”

These tests, known as natriuretic peptides (NP), measure the concentration of specific hormones that help regulate blood volume. When the heart isn’t strong enough, it releases more of these hormones as a result of the pressure of having to work harder, which can be a sign of heart failure. These tests should be used by GPs to guide referral of patients showing symptoms of heart failure to a specialist for assessment in accordance with the recommended guidelines from the National Institute for Health and Care Excellence (NICE) in the UK.

 

Andrea Roalfe, first author and senior researcher in medical statistics at the Nuffield Department of Primary Care Health Sciences, University of Oxford, said:

“We found that whilst NP test rates increased over time – with a significant upward trend in 2010 when NICE strengthened their recommendation to do this testing – the proportion of patients without NP testing prior to diagnosis remained high (reducing from 99.6% in 2004 to 76.7% in 2017), and most new diagnoses were made without an NP test.”

The researchers also found that most testing occurs in patients with more advanced disease. This, they say, suggests that progress has not been made in testing to achieve a timely diagnosis, and that many patients with more subtle clinical symptoms and signs may not currently be tested.

“A very positive finding from this work was that there was no evidence of inequalities across the country or difference by socioeconomic status – meaning that whether NP testing was carried out did not depend on these factors,” said Dr Taylor. “We did see more NP testing in older and more socially deprived groups, which we expected since these groups are typically at a higher risk of heart failure so are more likely to be tested.”

The authors conclude that more NP testing is likely needed from GPs, to prevent hospitalisation and help to diagnose HF at an earlier, more treatable stage, thereby increasing people’s quality of life and survival. These tests should be done in people with heart failure symptoms, such as breathlessness, fatigue and ankle swelling.

 

Study limitations:

  • This research is reliant on the accuracy of coding by GPs during the consultation.
  • The emergence of two distinct HF types, HFrEF and HFpEF, have only been coded very recently in GP records, therefore, analysis of trends by HF type were not possible in this study.
  • This study did not consider the potential influence of medications prescribed or ‘comorbid’ conditions such as obesity and atrial fibrillation, which may be relevant to both HF diagnosis and NP result interpretation.

Reference:

Andrea K Roalfe, Sarah L Lay-Flurrie, José M Ordóñez-Mena, Clare R Goyder, Nicholas R Jones, F D Richard Hobbs, Clare J Taylor, Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study, European Heart Journal, 2021;, ehab781, https://doi.org/10.1093/eurheartj/ehab781

Similar stories

Arm and shoulder disability and pain after breast cancer surgery reduced by exercise

The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise programme after their operation, a new study has found.

Willingness of Children and Adolescents to have COVID-19 Vaccination

The OxWell School Survey 2021 highlights that younger children and adolescents are the least willing to have the COVID-19 vaccination. These young people come from the most socioeconomically deprived backgrounds, feel less belonging to their school community and think they have probably had COVID-19 already.

Cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection

The research is highlighted in a special collection of studies that focus on early cancer detection, hailed by the Editors as “cutting edge, and potentially scalable, innovations that have the potential to inform research, policy, and clinical cancer management.”

The legacy of the CLAHRCs 2014-19 – 5 years of NIHR-funded applied health research

This publication compiles key research projects from the NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRCs).

NIHR ARC OxTV supported PRINCIPLE trial 'highly commended' for innovative use of health data

The PRINCIPLE trial, which the NIHR ARC OxTV was a fundamental part of setting up in the early days of the pandemic, has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.